CLINICAL_TRIALS
trial_result
· 2014-09-09
Clinical Trial Update: Effect of Rozerem on Sleep Among People With Traumatic Brain Injury [Phase 4]
Summary
This document provides an update on a Phase 4 trial evaluating ramelteon (Rozerem) for improving sleep in people with traumatic brain injury.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Kessler Foundation | Conditions: Insomnia, Brain Injury | Phase 4 | Status: UNKNOWN